Clinical tumour markers in lung cancerNIKLINSKI, J; FURMAN, M.European journal of cancer prevention. 1995, Vol 4, Num 2, pp 129-138, issn 0959-8278Article

Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancerMROCZKO, B; SZMITKOWSKI, M; NIKLINSKI, J et al.Clinical chemistry and laboratory medicine. 1999, Vol 37, Num 10, pp 959-962, issn 1434-6621Article

Clinical tumour markers in ovarian cancerMAZUREK, A; NIKLINSKI, J; LAUDANSKI, T et al.European journal of cancer prevention. 1998, Vol 7, Num 1, pp 23-35, issn 0959-8278Article

Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinomaNIKLINSKI, J; FURMAN, M; LAUDANSKI, J et al.Neoplasma. 1992, Vol 39, Num 5, pp 279-282, issn 0028-2685Article

The role of chemotherapy in early stage of non-small cell lung cancerSOUQUET, P. J; GERINIERE, L.Lung cancer. 2001, Vol 34, pp S155-S158, issn 0169-5002, SUP2Conference Paper

Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancerLAUDANSKI, J; BURZYKOWSKI, T; NIKLINSKA, W et al.Lung cancer. 1998, Vol 22, Num 3, pp 191-200, issn 0169-5002Article

evaluation of CYFRA 21-1 as a new marker for non-small cell lung cancerNIKLINSKI, J; FURMAN, M; CHYCZEWSKA, E et al.European journal of cancer prevention. 1994, Vol 3, Num 2, pp 227-230, issn 0959-8278Article

Principles of induction chemotherapy for non-small cell lung cancerJABŁONKA, St; FURMANIK, F; JABŁONKA, A et al.Lung cancer. 2001, Vol 34, pp S151-S153, issn 0169-5002, SUP2Conference Paper

The impact of immune responses on lung cancer and the development of new treatment modalitiesPLUYGERS, Eric; SADOWSKA, Ala; CHYCZEWSKI, Lech et al.Lung cancer. 2001, Vol 34, pp S71-S77, issn 0169-5002, SUP2Conference Paper

Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessmentPERWEZ HUSSAIN, S; HOFSETH, Lorne J; HARRIS, Curtis C et al.Lung cancer. 2001, Vol 34, pp S7-S15, issn 0169-5002, SUP2Conference Paper

CYFRA 21-1 as a tumour marker for bronchogenic carcinomaRAPELLINO, M; NIKLINSKI, J; PECCHIO, F et al.The European respiratory journal. 1995, Vol 8, Num 3, pp 407-410, issn 0903-1936Article

Cytokine secretion: clinical relevance of immunosuppression in non-small cell lung cancerNEUNER, A; SCHINDEL, M; WILDENBERG, U et al.Lung cancer. 2001, Vol 34, pp S79-S82, issn 0169-5002, SUP2Conference Paper

Drug resistance in non-small cell lung cancerMONZO, Mariano; ROSELL, Rafael; TARON, Miquel et al.Lung cancer. 2001, Vol 34, pp S91-S94, issn 0169-5002, SUP2Conference Paper

Neoadjuvant strategies for non-small cell lung cancerVAN ZANDWIJK, Nico.Lung cancer. 2001, Vol 34, pp S145-S150, issn 0169-5002, SUP2Conference Paper

Surgery for non-small cell lung cancerVAN SCHIL, Paul E.Lung cancer. 2001, Vol 34, pp S127-S132, issn 0169-5002, SUP2Conference Paper

The preoperative study of mediastinal lymph nodes metastasis in lung cancer by endoscopic ultrasonography (EUS) and helical computed tomography (CT)LAUDANSKI, Jerzy; KOZLOWSKI, Miroslaw; NIKLINSKI, Jacek et al.Lung cancer. 2001, Vol 34, pp S123-S126, issn 0169-5002, SUP2Conference Paper

Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancerNIKLINSKI, J; BURZYKOWSKI, T; NIKLINSKA, W et al.The European respiratory journal. 1998, Vol 12, Num 6, pp 1424-1428, issn 0903-1936Article

Endobronchial ultrasoundBURGERS, J. A; HERTH, F; BECKER, H. D et al.Lung cancer. 2001, Vol 34, pp S109-S113, issn 0169-5002, SUP2Conference Paper

Moving to the routine management of pre symptomatic lung cancerMULSHINE, James L; HONG, Sung; MARTINEZ, Alfredo et al.Lung cancer. 2001, Vol 34, pp S1-S5, issn 0169-5002, SUP2Conference Paper

Radiotherapy for non-small cell lung cancerJASSEM, Jacek.Lung cancer. 2001, Vol 34, pp S177-S180, issn 0169-5002, SUP2Conference Paper

Surgical treatment of stage III non-small cell lung cancerORLOWSKI, Tadeusz M; SZCZESNY, Tomasz J.Lung cancer. 2001, Vol 34, pp S137-S143, issn 0169-5002, SUP2Conference Paper

Towards a biological staging model for operable non-small cell lung cancerO'BYRNE, K. J; COX, G; HARRIS, A. L et al.Lung cancer. 2001, Vol 34, pp S83-S89, issn 0169-5002, SUP2Conference Paper

Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancerNIKLINSKI, J; CHYCZEWSKA, E; FURMAN, M et al.Neoplasma. 1993, Vol 40, Num 5, pp 305-308, issn 0028-2685Article

Molecular genetic abnormalities in premalignant lung lesions : biological and clinical implicationsNIKLINSKI, J; NIKLINSKA, W; CHYCZEWSKI, L et al.European journal of cancer prevention. 2001, Vol 10, Num 3, pp 213-226, issn 0959-8278Article

Molecular biology of lung cancerKAYE, Frederic J.Lung cancer. 2001, Vol 34, pp S35-S41, issn 0169-5002, SUP2Conference Paper